lapatinib

Generic: lapatinib

Labeler: teva pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lapatinib
Generic Name lapatinib
Labeler teva pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

lapatinib ditosylate 250 mg/1

Manufacturer
Teva Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 0480-3237
Product ID 0480-3237_f259a366-78fc-4919-9bcb-748314a0581c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217968
Listing Expiration 2026-12-31
Marketing Start 2024-12-19

Pharmacologic Class

Classes
kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04803237
Hyphenated Format 0480-3237

Supplemental Identifiers

RxCUI
672149
UNII
G873GX646R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lapatinib (source: ndc)
Generic Name lapatinib (source: ndc)
Application Number ANDA217968 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51)
source: ndc

Packages (1)

Ingredients (1)

lapatinib ditosylate (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f259a366-78fc-4919-9bcb-748314a0581c", "openfda": {"unii": ["G873GX646R"], "rxcui": ["672149"], "spl_set_id": ["b09abf73-1eef-4e12-b400-c030d546d223"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51)", "package_ndc": "0480-3237-51", "marketing_start_date": "20241219"}], "brand_name": "Lapatinib", "product_id": "0480-3237_f259a366-78fc-4919-9bcb-748314a0581c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0480-3237", "generic_name": "Lapatinib", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lapatinib", "active_ingredients": [{"name": "LAPATINIB DITOSYLATE", "strength": "250 mg/1"}], "application_number": "ANDA217968", "marketing_category": "ANDA", "marketing_start_date": "20241219", "listing_expiration_date": "20261231"}